MedTrace Logo

Exercise and Prevention of Syncope: EXPOSE

NCT00203593 · Status: SUSPENDED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2007-03-14

No results posted yet for this study

Summary

The purpose of this study is to determine whether eight weeks of exercise performed at an intensity of approximately 65% VO2max will improve symptoms associated with fainting (vasovagal syncope).

Conditions

  • Syncope

Interventions

BEHAVIORAL

Exercise

DEVICE

Blood volume

PROCEDURE

VO2max test

PROCEDURE

Lower body negative pressure

BEHAVIORAL

Heart Rate

PROCEDURE

Blood Pressure

BEHAVIORAL

Total Peripheral Resistance

Sponsors & Collaborators

  • University of Calgary

    lead OTHER

Principal Investigators

  • Robert S Sheldon, MD PhD · University of Calgary

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-03-31
Completion
2007-06-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00203593 on ClinicalTrials.gov